Cardiac assessment prior to non-cardiac surgery

Intern Med J. 2016 Aug;46(8):932-41. doi: 10.1111/imj.13133.

Abstract

Background: Increasingly, patients undergoing non-cardiac surgery are older and have more comorbidities yet preoperative cardiac assessment appears haphazard and unsystematic. We hypothesised that patients at high cardiac risk were not receiving adequate cardiac assessment, and patients with low-cardiac risk were being over-investigated.

Aims: To compare in a representative sample of patients undergoing non-cardiac surgery the use of cardiac investigations in patients at high and low preoperative cardiac risk.

Methods: We examined cardiac assessment patterns prior to elective non-cardiac surgery in a representative sample of patients. Cardiac risk was calculated using the Revised Cardiac Risk Index.

Results: Of 671 patients, 589 (88%) were low risk and 82 (12%) were high risk. We found that nearly 14% of low-risk and 45% of high-risk patients had investigations for coronary ischaemia prior to surgery. Vascular surgery had the highest rate of investigation (38%) and thoracic patients the lowest rate (14%). Whilst 78% of high-risk patients had coronary disease, only 46% were on beta-blockers, 49% on aspirin and 77% on statins. For current smokers (17.3% of cohort, n = 98), 60% were advised to quit pre-op.

Conclusions: Practice patterns varied across surgical sub-types with low-risk patients tending to be over-investigated and high-risk patients under-investigated. A more systemised approach to this large group of patients could improve clinical outcomes, and more judicious use of investigations could lower healthcare costs and increase efficiency in managing this cohort.

Keywords: cardiac; preoperative care; surgery.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Aspirin / therapeutic use
  • Australia
  • Comorbidity
  • Coronary Artery Disease / therapy*
  • Drug Therapy
  • Elective Surgical Procedures*
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Middle Aged
  • Outcome Assessment, Health Care*
  • Patient Care Planning
  • Preoperative Care / methods*
  • Risk Assessment
  • Risk Factors
  • Vascular Surgical Procedures*

Substances

  • Adrenergic beta-Antagonists
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Aspirin